about
Guillain Barré syndrome and other immune mediated neuropathies: Diagnosis and classificationGuillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or VaccinationThrombin regulation of synaptic transmission and plasticity: implications for health and diseaseNeuropsychiatric lupus: a mosaic of clinical presentationsAPOE genotype is a major predictor of long-term progression of disability in MSAntibodies to ganglioside GM1 in patients with Alzheimer's diseaseTreatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS)Deficiency of nicotinic acetylcholine receptor beta 4 subunit causes autonomic cardiac and intestinal dysfunctionChanges in axonal morphology in experimental autoimmune neuritis as studied by high b-value q-space (1)H and (2)H DQF diffusion magnetic resonance spectroscopy.Antibodies to brain antigens following stroke.Apolipoprotein E4 in Parkinson disease and dementia: new data and meta-analysis of published studies.Hyperactivity in a mouse model of the antiphospholipid syndrome.Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome.Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model.Features associated with epilepsy in the antiphospholipid syndrome.Web-based multi-center data management system for clinical neuroscience research.Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation.Rapidly progressive Creutzfeldt-Jakob disease in patients with Familial Mediterranean FeverAncestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease.The effects of APOE genotype on age at onset and progression of neurodegenerative diseases.Immunoglobulin-mediated neuro-cognitive impairment: new data and a comprehensive review.Snord 3A: a molecular marker and modulator of prion disease progressionInfection and vaccination in chronic fatigue syndrome: myth or reality?16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupus.Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice.Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.The Ras antagonist, farnesylthiosalicylic acid (FTS), decreases fibrosis and improves muscle strength in dy/dy mouse model of muscular dystrophy.Neurological and neuroendocrine-cytokine inter-relationship in the antiphospholipid syndrome.Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional studyTLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells.The Creutzfeldt-Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression.Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002.Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies.Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndromeCNS dysfunction in the antiphospholipid syndrome.Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis.Significant changes in the levels of secreted cytokines in brains of experimental antiphospholipid syndrome miceThe interface of multiple sclerosis and antiphospholipid antibodies.Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein, affecting neuronal cells in vitro.The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro.
P50
Q22252522-BA748355-8804-4B4E-8F72-6BE29306B71BQ24276196-4484BC8E-9BFF-433C-8535-9EE1B3EBC930Q26827343-84A33427-356A-49B7-A848-7DF823080631Q27027588-B801CD91-8081-4AF7-BD52-17C095729367Q28199870-0F2E77AE-68F4-4A75-8D3B-69414F29EFDDQ28297154-5CE4F46A-41DC-4C5E-A995-0689526DDB96Q28365993-D828F02A-918E-43A8-9B43-D3CB63441F2AQ28505022-1AE98AB7-5D6B-4C21-BD54-97CF9927BA31Q30703129-07987826-B3B5-4B7B-B1DC-BC0BA9863BB4Q32062082-913E4EEC-25F1-4196-A15F-2975768828D8Q32068531-7F95D5AE-F87A-4054-AADE-F9CFE06E5C39Q33338363-492D7B8C-CA5C-46AD-B705-0FE8DE944170Q33346978-FCFBB7C6-CDC1-4150-AB13-3775C04F1B25Q33360884-7CAE9B51-50D0-49CD-8672-9D7ECE7F3065Q33361525-8F3DE8E3-0A33-4549-8D9A-EED012C9222BQ33535320-C2D76653-E484-4D2A-BEE1-D9E4514FC37EQ33591914-20BD2857-5DF7-43EB-BC62-A69AA9421B0FQ33955559-CA24AC34-19F7-4736-B20F-EF6F9F33CD52Q34389352-634FE2F3-B7EA-40D1-9BBD-05CE49875E2BQ34416757-FA67653A-CBB4-40AE-87B6-E41250F45CCBQ34550430-EA4610B4-89E6-4C48-BA28-9565234B4A23Q34563111-2B57828C-E10D-4F75-AB85-C082F8F8A573Q34609090-6374150F-4C6D-48A8-B5C5-5C14D2AF8813Q34654431-60ADF799-B72E-4164-9942-3E62291474E8Q34659598-E8A3726D-2FA5-49CF-9090-D228ECA3B0F6Q34677865-F3BA412E-FDCE-46C5-9355-A7FBCCD1AA0BQ34708324-B08A95F0-5324-422B-B74D-2954BC436D55Q34735687-292C5E4B-3853-4441-9BF4-8E4680AB5570Q34926430-07C038E7-BD4A-4AC1-9952-7E20A8201493Q34953661-1CB762C1-EE0E-425C-90A8-AB30E502F885Q35000257-D5331155-074B-4063-BB6A-C6623CFAB7B3Q35189292-CA1BD443-7270-43C8-A459-43271D9C354FQ35189295-D2A43F3D-F6B3-48F6-8FD6-70F774382E80Q35554870-FA8CA708-D50C-44E5-9837-A0CB124A73EEQ35625224-33124466-32AD-4E43-B3F0-3A55F8C7D6E2Q35636977-E64687DB-B2A4-496E-8E71-037057FE5361Q35791670-58812595-197D-4D6A-AFF5-479C754E5921Q35928731-6324286A-1B18-45C7-B7E2-2378F0EDF093Q36011424-60B88A47-5E9D-49F6-83B9-AD476FA81CAAQ36149771-8146A432-DD8E-4F1D-A477-4221B4FA0EB3
P50
description
forsker
@nb
researcher
@en
ricercatore
@it
name
Joab Chapman
@da
Joab Chapman
@de
Joab Chapman
@en
Joab Chapman
@fr
Joab Chapman
@nb
Joab Chapman
@nl
Joab Chapman
@nn
Joab Chapman
@sv
type
label
Joab Chapman
@da
Joab Chapman
@de
Joab Chapman
@en
Joab Chapman
@fr
Joab Chapman
@nb
Joab Chapman
@nl
Joab Chapman
@nn
Joab Chapman
@sv
prefLabel
Joab Chapman
@da
Joab Chapman
@de
Joab Chapman
@en
Joab Chapman
@fr
Joab Chapman
@nb
Joab Chapman
@nl
Joab Chapman
@nn
Joab Chapman
@sv
P214
P106
P2038
Joab_Chapman
P21
P214
P31
P734
P7859
viaf-298937801